Literature DB >> 17914973

Comparison of surgical outcomes for small hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a Chinese experience.

Qiang Li1, Huikai Li, Yu Qin, P Peter Wang, Xishan Hao.   

Abstract

BACKGROUND: Although both hepatitis B virus (HBV) and hepatitis C virus (HCV) infection are well recognized risk factors for hepatocellular carcinoma (HCC), little is known with respect to how HBV and HCV infection affect HCC recurrence in postoperative HCC Chinese patients. The objective of this study was to determine if differences exist in preoperative characteristics and postoperative HCC recurrence in patients with different HBV and HCV infection status.
METHODS: The study population consisted of 413 patients undergoing a curative resection at Tianjin Cancer Hospital for small HCC (< or =3 cm) from January 1997 to December 2003. The patients were divided into four groups: HCV only (n = 75), HBV only (n = 251), HBV and HCV (n = 33), and neither HBV nor HCV (NBNC, n = 54). The preoperative status and postoperative HCC recurrence were recorded. Survival analyses were used to assess the impact of HBV/HCV status on HCC recurrence.
RESULTS: Patients with HCV had a significant association with older age, lower mean preoperative platelet counts and albumin levels, higher mean prothrombin time, alanine aminotransferase and total bilirubin levels and multinodular tumors during diagnosis. Patients with HCV also had significantly less differentiated tumors and a higher incidence of vascular invasion and cirrhosis when compared to the other groups. During the follow-up, the HCV group showed a higher incidence of intrahepatic recurrence and multiple recurrent lesions than the other patients.
CONCLUSIONS: Patients with HCV infection tended to be older, and were characterized by more severe cirrhosis and higher incidence of tumor multicentricity. The statistically significant determinants for reoccurrence in patients with small HCC were HCV infection, presence of vascular invasion and multiple tumors.

Entities:  

Mesh:

Year:  2007        PMID: 17914973     DOI: 10.1111/j.1440-1746.2006.04619.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  25 in total

1.  Clinical outcome of hepatectomy for hepatocellular carcinomas≤2 cm.

Authors:  Tokihiko Sawada; Keiichi Kubota; Junji Kita; Masato Kato; Takayuki Shiraki; KyungHwa Park; Mitsugi Shimoda
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

2.  A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery.

Authors:  Wei-Yu Kao; Chien-Wei Su; Gar-Yang Chau; Wing-Yiu Lui; Chew-Wun Wu; Jaw-Ching Wu
Journal:  World J Surg       Date:  2011-04       Impact factor: 3.352

Review 3.  Surgical approach for hepatitis C virus-related hepatocellular carcinoma.

Authors:  Junichi Shindoh; Masaji Hashimoto; Goro Watanabe
Journal:  World J Hepatol       Date:  2015-01-27

4.  Epidemiology and survival of patients with hepatocellular carcinoma in Southern Germany.

Authors:  Gabriele Kirchner; Georgi Kirovski; Alexandra Hebestreit; Jürgen Schölmerich; Hans Jürgen Schlitt; Oliver Stoeltzing; Claus Hellerbrand
Journal:  Int J Clin Exp Med       Date:  2010-06-10

5.  Impact of Viral Etiology on Postoperative De Novo Recurrence After Hepatectomy for Hepatocellular Carcinoma in Cirrhotic Patients.

Authors:  Kazunari Sasaki; Junichi Shindoh; Yujiro Nishioka; Georgios A Margonis; Toshitaka Sugawara; Nikolaos Andreatos; Masaji Hashimoto; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-01-03       Impact factor: 3.452

6.  Resection or transplant-listing for solitary hepatitis C-associated hepatocellular carcinoma: an intention-to-treat analysis.

Authors:  Hiroshi Sogawa; Brian Shrager; Ghalib Jibara; Parissa Tabrizian; Sasan Roayaie; Myron Schwartz
Journal:  HPB (Oxford)       Date:  2012-08-30       Impact factor: 3.647

7.  Surgical management of early-stage hepatocellular carcinoma: resection or transplantation?

Authors:  Emily C Bellavance; Kimberly M Lumpkins; Gilles Mentha; Hugo P Marques; Lorenzo Capussotti; Carlo Pulitano; Pietro Majno; Paulo Mira; Laura Rubbia-Brandt; Alessandro Ferrero; Luca Aldrighetti; Steven Cunningham; Nadia Russolillo; Benjamin Philosophe; Eduardo Barroso; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2008-08-15       Impact factor: 3.452

8.  Clinical factors that affect the outcomes after anatomical versus non-anatomical resection for hepatocellular carcinoma.

Authors:  Takehito Yamamoto; Shintaro Yagi; Kenji Uryuhara; Satoshi Kaihara; Ryo Hosotani
Journal:  Surg Today       Date:  2016-08-08       Impact factor: 2.549

9.  Viral status at the time of liver transplantation for hepatocellular carcinoma: a modern predictor of longterm survival.

Authors:  Ryan T Groeschl; Johnny C Hong; Kathleen K Christians; Kiran K Turaga; Susan Tsai; Charles H C Pilgrim; T Clark Gamblin
Journal:  HPB (Oxford)       Date:  2013-06-19       Impact factor: 3.647

10.  Successful surgical resection for peritoneal implantation of hepatocellular carcinoma at the paracardial portion.

Authors:  Yuichi Sanada; Shinji Osada; Yasuharu Tokuyama; Yoshihiro Tanaka; Takao Takahashi; Kazuya Yamaguchi; Kazuhiro Yoshida
Journal:  J Oncol       Date:  2009-12-16       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.